Treatment

CD19CAR T-cells clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE1
Immunotherapy Using CAR T-cells to Target CD19 for Relapsed/Refractory CD19+ Primary CNS Lymphoma
The CAROUSEL trial explores a new treatment called CAR T-cell therapy for adults with a type of brain lymphoma that has returned or not responded to usual treatments. It checks if the therapy is safe and how well it works.
For: Primary CNS Lymphoma
United Kingdom